1355025-99-8

Basic information

• Product Name: 3-[2,3-(dihydro-3-(3-hydroxycarbonylphenyl)-2-thioxo-1H-imidazol-5-yl)]-8-methoxy-2H-chromen-2-one
• Synonyms: 3-[2,3-(dihydro-3-(3-hydroxycarbonylphenyl)-2-thioxo-1H-imidazol-5-yl)]-8-methoxy-2H-chromen-2-one
• CAS NO: 1355025-99-8
• Molecular Weight: 394.408
• Mol File: 1355025-99-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[2,3-(dihydro-3-(3-hydroxycarbonylphenyl)-2-thioxo-1H-imidazol-5-yl)]-8-methoxy-2H-chromen-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2,3-(dihydro-3-(3-hydroxycarbonylphenyl)-2-thioxo-1H-imidazol-5-yl)]-8-methoxy-2H-chromen-2-one(1355025-99-8)
• EPA Substance Registry System: 3-[2,3-(dihydro-3-(3-hydroxycarbonylphenyl)-2-thioxo-1H-imidazol-5-yl)]-8-methoxy-2H-chromen-2-one(1355025-99-8)

Safety Data

• Hazardous Substances Data: 1355025-99-8(Hazardous Substances Data)

Upstream product

• 148-53-8 3-methoxy-2-hydroxybenzaldehyde 
• 106578-18-1 3-(2-bromoacetyl)-8-methoxy-2H-chromen-2-one 
• 5452-39-1 3-acetyl-8-methoxy-2H-chromen-2-one 
• 1355025-91-0 3-[2-(3-hydroxycarbonyl)phenylaminoacetyl]-8-methoxy-2H-chromen-2-one 
• 1147550-11-5 ammonium thiocyanate 

Relevant articles and documents

Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: A first round of lead optimization

Osteoarthritis (OA) is the leading cause of joint pain and disability in middle-aged and elderly patients, and is characterized by progressive loss of articular cartilage. Among the various matrix metalloproteinases (MMPs), MMP-13 is specifically expresse